Tipranavir + Abacavir Interaction
Unknowninteraction on record
Description
Nucleoside Reverse Transcriptase Inhibitors: Abacavir ↓ Abacavir AUC by approximately 40% Clinical relevance of reduction in abacavir levels not established. Dose adjustment of abacavir cannot be recommended at this time.
Source: FDA drug label - tipranavir